SCHEMBL8523531

SCHEMBL8523531

CCCC(c1ccc(NC(=O)c2ccccc2)c2c1C(C(=O)NCC(F)(F)F)c1ccccc1-2)N1CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ CYP2C9 P11712 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ ACHE P22303 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ ACKR3 P25106 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ MMP14 P50281 1/20 0.32
▸ MTTP P55157 1/20 0.31
▸ CCR8 P51685 1/20 0.31
▸ HDAC3 O15379 1/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ CYP2C19 P33261 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8483448 0.90 POLB (0.33) SLC6A2SLC6A3POLBALDH1A1SMN1; SMN2
SCHEMBL8479995 0.89 MEN1 (0.36) ALDH1A1KMT2AMEN1MTTPMAPT
SCHEMBL8653095 0.88 PRMT5 (0.33) POLBMTTP
SCHEMBL8480386 0.87 POLB (0.33) POLBALDH1A1LMNAGAA
SCHEMBL8479937 0.85 MEN1 (0.35) ALDH1A1KMT2AMEN1MTTPMAPT
SCHEMBL8667993 0.84 ACKR3 (0.37) SLC6A2SLC6A3POLBCYP2C9ALDH1A1
SCHEMBL8503674 0.79 CCR2 (0.36) SLC6A2SLC6A3POLBACKR3MTTP
SCHEMBL8662744 0.78 ACKR3 (0.36) SLC6A2SLC6A3CYP2C9ALDH1A1SLC6A4
SCHEMBL8523535 0.77 KMT2A (0.40) POLBCYP2C9ALDH1A1KMT2AMEN1
SCHEMBL8668004 0.75 POLB (0.37) POLBCYP2C9ALDH1A1ACKR3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
Send feedback